AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase

Journal of Cellular Physiology

Volumn 227, Issue 8, 2012, Pages 3053-3062

  Su, Kuo Hui ^a   Yu, Yuan Bin ^a,b   Hou, Hsin Han ^a   Zhao, Jin Feng ^a   Kou, Yu Ru ^a   Cheng, Li Ching ^c   Shyue, Song Kun ^d   Lee, Tzong Shyuan ^a,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIUM; ERYTHROPOIETIN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHORYLATION; PYRAZOLES; PYRIMIDINES; SIGNAL TRANSDUCTION;

MUS; MUS MUSCULUS;

EID: 84860447268     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23052     Document Type: Article

References (51)

1. Alderton WK, Cooper CE, Knowles RG. 2001. Nitric oxide synthases: Structure, function and inhibition. Biochem J 357: 593-615.
2. Arad M, Seidman CE, Seidman JG. 2007. AMP-activated protein kinase in the heart: Role during health and disease. Circ Res 100: 474-488.
3. Boyle JG, Salt IP, McKay GA. 2010. Metformin action on AMP-activated protein kinase: A translational research approach to understanding a potential new therapeutic target. Diabet Med 27: 1097-1106.
4. Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, Cerami A. 2004. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA 101: 14907-14912.
5. Camacho RC, Donahue EP, James FD, Berglund ED, Wasserman DH. 2006. Energy state of the liver during short-term and exhaustive exercise in C57BL/6J mice. Am J Physiol Endocrinol Metab 290: E405-E408.
6. Chen Z, Peng IC, Sun W, Su MI, Hsu PH, Fu Y, Zhu Y, DeFea K, Pan S, Tsai MD, Shyy JY. 2009. AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633. Circ Res 104: 496-505.
7. Dong Y, Zhang M, Wang S, Liang B, Zhao Z, Liu C, Wu M, Choi HC, Lyons TJ, Zou MH. 2010. Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo. Diabetes 59: 1386-1396.
8. Durante PE, Mustard KJ, Park SH, Winder WW, Hardie DG. 2002. Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. Am J Physiol Endocrinol Metab 283: E178-E186.
9. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK. 1998. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95: 8880-8885.
10. Goirand F, Solar M, Athea Y, Viollet B, Mateo P, Fortin D, Leclerc J, Hoerter J, Ventura-Clapier R, Garnier A. 2007. Activation of AMP kinase α1 subunit induces aortic vasorelaxation in mice. J Physiol 581: 1163-1171.
11. Hirschler-Laszkiewicz I, Tong Q, Waybill K, Conrad K, Keefer K, Zhang W, Chen SJ, Cheung JY, Miller BA. 2011. The transient receptor potential (TRP) channel TRPC3 TRP domain and AMP-activated protein kinase binding site are required for TRPC3 activation by erythropoietin. J Biol Chem 286: 30636-30646.
12. Hurst D, Taylor EB, Cline TD, Greenwood LJ, Compton CL, Lamb JD, Winder WW. 2005. AMP-activated protein kinase kinase activity and phosphorylation of AMP-activated protein kinase in contracting muscle of sedentary and endurance-trained rats. Am J Physiol Endocrinol Metab 289: E710-E715.
13. Jorgensen SB, Richter EA, Wojtaszewski JF. 2006. Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise. J Physiol 574: 17-31.
14. Kawashima S, Yokoyama M. 2004. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 24: 998-1005.
15. Kingwell BA. 2000. Nitric oxide-mediated metabolic regulation during exercise: Effects of training in health and cardiovascular disease. FASEB J 14: 1685-1696.
16. Klopsch C, Furlani D, Gäbel R, Li W, Pittermann E, Ugurlucan M, Kundt G, Zingler C, Titze U, Wang W, Ong LL, Wagner K, Li RK, Ma N, Steinhoff G. 2009. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cell Mol Med 13: 664-679.
17. Laderoute KR, Amin K, Calaoagan JM, Knapp M, Le T, Orduna J, Foretz M, Viollet B. 2006. 5′-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments. Mol Cell Biol 26: 5336-5347.
18. LeBrasseur NK, Kelly M, Tsao TS, Farmer SR, Saha AK, Ruderman NB, Tomas E. 2006. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am J Physiol Endocrinol Metab 291: E175-E181.
19. Li C. Keaney JF, Jr. 2010. AMP-activated protein kinase: A stress-responsive kinase with implications for cardiovascular disease Curr Opin Pharmacol 10: 111-115.
20. Li X, Han Y, Pang W, Li C, Xie X, Shyy JY, Zhu Y. 2008. AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28: 1789-1795.
21. Li D, Wang D, Wang Y, Ling W, Feng X, Xia M. 2010. Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice. J Biol Chem 285: 33499-33509.
22. Li XJ, Wang XW. Du YJ. 2011. Protective effects of erythropoietin on myocardial infarction in rats: The role of AMP-activated protein kinase signaling pathway Am J Med Sci 342: 153-159.
23. Lu KY, Ching LC, Su KH, Yu YB, Kou YR, Hsiao SH, Huang YC, Chen CY, Cheng LC, Pan CC, Lee TS. 2010. Erythropoietin suppresses the formation of macrophage foam cells: Role of liver X receptor alpha. Circulation 121: 1828-1837.
24. Lundby C, Gassmann M, Pilegaard H. 2006. Regular endurance training reduces the exercise induced HIF-1α and HIF-2α mRNA expression in human skeletal muscle in normoxic conditions. Eur J Appl Physiol 96: 363-369.
25. Murphy RT, Mogensen J, McGarry K, Bahl A, Evans A, Osman E, Syrris P, Gorman G, Farrell M, Holton JL, Hanna MG, Hughes S, Elliott PM, Macrae CA, McKenna WJ. 2005. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: Natural history. J Am Coll Cardiol 45: 922-930.
26. Musi N, Hirshman MF, Arad M, Xing Y, Fujii N, Pomerleau J, Ahmad F, Berul CI, Seidman JG, Tian R, Goodyear LJ. 2005. Functional role of AMP-activated protein kinase in the heart during exercise. FEBS Lett 579: 2045-2050.
27. Nagata D, Takeda R, Sata M, Satonaka H, Suzuki E, Nagano T, Hirata Y. 2004. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 110: 444-451.
28. Owlya R, Vollenweider L, Trueb L, Sartori C, Lepori M, Nicod P, Scherrer U. 1997. Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans. Circulation 96: 3897-3903.
29. Roberts D, Smith DJ, Donnelly S, Simard S. 2000. Plasma-volume contraction and exercise-induced hypoxaemia modulate erythropoietin production in healthy humans. Clin Sci (Lond) 98: 39-45.
30. Ruschitzka FT, Wenger RH, Stallmach T, Quaschning T, de Wit C, Wagner K, Labugger R, Kelm M, Noll G, Rulicke T, Shaw S, Lindberg RL, Rodenwaldt B, Lutz H, Bauer C, Luscher TF, Gassmann M. 2000. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci USA 97: 11609-11613.
31. Ryu JH, Cho YS, Chun YS, Park JW. 2008. Myocardial SSAT induction via AMPK signaling and its implication for ischemic injury. Biochem Biophys Res Commun 366: 438-444.
32. Sasaki Y, Noguchi T, Yamamoto E, Giddings JC, Ikeda K, Yamamoto J, Yamori Y. 2004. Effects of voluntary exercise on cerebral thrombosis and endothelial function in spontaneously hypertensive rats (SHRSP/Izm). Clin Exp Pharmacol Physiol 31 S47-S48.
33. Satoh K, Kagaya Y, Nakano M, Ito Y, Ohta J, Tada H, Karibe A, Minegishi N, Suzuki N, Yamamoto M, Ono M, Watanabe J, Shirato K, Ishii N, Sugamura K, Shimokawa H. 2006. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation 113: 1442-1450.
34. Sessa WC. 2004. eNOS at a glance. J Cell Sci 117: 2427-2429.
35. Siri WE, Van Dyke DC, Winchell HS, Pollycove M, Parker HG, Cleveland AS. 1966. Early erythropoietin, blood, and physiological responses to severe hypoxia in man. J Appl Physiol 21: 73-80.
36. Stahmann N, Woods A, Spengler K, Heslegrave A, Bauer R, Krause S, Viollet B, Carling D, Heller R. 2010. Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase. J Biol Chem 285: 10638-10652.
37. Stapleton D, Woollatt E, Mitchelhill KI, Nicholl JK, Fernandez CS, Michell BJ, Witters LA, Power DA, Sutherland GR, Kemp BE. 1997. AMP-activated protein kinase isoenzyme family: Subunit structure and chromosomal location. FEBS Lett 409: 452-456.
38. Steinberg GR, Kemp BE. 2009. AMPK in health and disease. Physiol Rev 89: 1025-1078.
39. Stohlman F, Jr., Ebbe S, Morse B, Howard D, Donovan J. 1968. Regulation of erythropoiesis. XX. Kinetics of red cell production. Ann N Y Acad Sci 149: 156-172.
40. Su KH, Shyue SK, Kou YR, Ching LC, Chiang AN, Yu YB, Chen CY, Pan CC, Lee TS. 2011. β common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase. J Cell Physiol 226: 3330-3339.
41. Sun W, Lee TS, Zhu M, Gu C, Wang Y, Zhu Y, Shyy JY. 2006. Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114: 2655-2662.
42. Sutina L, Sautin Y, Beem E, Zhou Z, Schuler A, Brennan J, Zharikov SI, Diao Y, Bungert J, Segal MS. 2010. Induction of nitric oxide by erythropoietin is mediated by the β common receptor and requires interaction with VEGF receptor 2. Blood 115: 896-905.
43. Urao N, Okigaki M, Yamada H, Aadachi Y, Matsuno K, Matsui A, Matsunaga S, Tateishi K, Nomura T, Takahashi T, Tatsumi T, Matsubara H. 2006. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98: 1405-1413.
44. van Dijk TB, Caldenhoven E, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP. 1997. Multiple tyrosine residues in the intracellular domain of the common beta subunit of the interleukin 5 receptor are involved in activation of STAT5. FEBS Lett 412: 161-164.
45. Vogel J, Kiessling I, Heinicke K, Stallmach T, Ossent P, Vogel O, Aulmann M, Frietsch T, Schmid-Schonbein H, Kuschinsky W, Gassmann M. 2003. Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood 102: 2278-2284.
46. Wadley GD, Lee-Young RS, Canny BJ, Wasuntarawat C, Chen ZP, Hargreaves M, Kemp BE, McConell GK. 2006. Effect of exercise intensity and hypoxia on skeletal muscle AMPK signaling and substrate metabolism in humans. Am J Physiol Endocrinol Metab 290: E694-E702.
47. Wong AK, Howie J, Petrie JR, Lang CC. 2009. AMP-activated protein kinase pathway: A potential therapeutic target in cardiometabolic disease. Clin Sci (Lond) 116: 607-620.
48. Xu Y, Tian Y, Wei HJ, Chen J, Dong JF, Zacharek A, Zhang JN. 2011. Erythropoietin increases circulating endothelial progenitor cells and reduces the formation and progression of cerebral aneurysm in rats. Neuroscience 181: 292-299.
49. Zhang Y, Lee TS, Kolb EM, Sun K, Lu X, Sladek FM, Kassab GS, Garland T, Jr., Shyy JY. 2006. AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. Arterioscler Thromb Vasc Biol 26: 1281-1287.
50. Zhang QJ, McMillin SL, Tanner JM, Palionyte M, Abel ED, Symons JD. 2009. Endothelial nitric oxide synthase phosphorylation in treadmill-running mice: Role of vascular signalling kinases. J Physiol 587: 3911-3920.
51. Zhu BL, Tanaka S, Ishikawa T, Zhao D, Li DR, Michiue T, Quan L, Maeda H. 2008. Forensic pathological investigation of myocardial hypoxia-inducible factor-1 alpha, erythropoietin and vascular endothelial growth factor in cardiac death. Leg Med (Tokyo) 10: 11-19.